TNF-α抑制剂联合IL-4、IL-17、IL-23或JAK抑制剂治疗多发性、严重皮肤病和/或胃肠道或风湿病患者

IF 3.9 4区医学 Q2 DERMATOLOGY

Journal of Cutaneous Medicine and Surgery Pub Date : 2025-07-01 Epub Date: 2025-01-31 DOI:10.1177/12034754251316534

M Grace Hren, Saakshi Khattri

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Combining TNF-α Inhibitors With IL-4, IL-17, IL-23, or JAK Inhibitors in Patients with Multiple, Severe Dermatologic Conditions and/or Gastrointestinal or Rheumatologic Disease.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cutaneous Medicine and Surgery 医学-皮肤病学

CiteScore

3.70

自引率

4.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Journal of Cutaneous Medicine and Surgery (JCMS) aims to reflect the state of the art in cutaneous biology and dermatology by providing original scientific writings, as well as a complete critical review of the dermatology literature for clinicians, trainees, and academicians. JCMS endeavours to bring readers cutting edge dermatologic information in two distinct formats. Part of each issue features scholarly research and articles on issues of basic and applied science, insightful case reports, comprehensive continuing medical education, and in depth reviews, all of which provide theoretical framework for practitioners to make sound practical decisions. The evolving field of dermatology is highlighted through these articles. In addition, part of each issue is dedicated to making the most important developments in dermatology easily accessible to the clinician by presenting well-chosen, well-written, and highly organized information in a format that is interesting, clearly presented, and useful to patient care.